UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 6, pp. 511 - 522
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Single-Blind Method | Glucocorticoids - administration & dosage | Myasthenia Gravis - classification | Prednisone - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Hospitalization | Young Adult | Thymectomy | Adolescent | Adult | Female | Aged | Myasthenia Gravis - drug therapy | Myasthenia Gravis - surgery | Treatment outcome | Usage | Care and treatment | Myasthenia gravis | Analysis | Clinical trials | Prednisone | Dosage and administration | Lymphatic system | Neuromuscular diseases | Patients | Evidence-based medicine | Quality of life | Neurological diseases | Immunosuppression | Surgery | Neuromuscular junctions | Myasthenia | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 08/2017, Volume 89, Issue 11, pp. 1127 - 1134
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Myasthenia Gravis - complications | Myocarditis - chemically induced | Autoantibodies - blood | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Middle Aged | Myocarditis - drug therapy | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Myositis - chemically induced | Antineoplastic Agents - therapeutic use | Myositis - complications | Activities of Daily Living | Databases, Pharmaceutical | Neoplasms - blood | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Myositis - drug therapy | Creatine Kinase - blood | Myasthenia Gravis - blood | Myocarditis - complications | Japan | Treatment Outcome | Biomarkers - blood | Myocarditis - blood | Myositis - blood | Myasthenia Gravis - chemically induced | Neoplasms - drug therapy | Nivolumab | Aged | Myasthenia Gravis - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2015, Volume 14, Issue 10, pp. 1023 - 1036
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Myasthenia Gravis - classification | Myasthenia Gravis - immunology | Myasthenia Gravis - drug therapy | Humans | Myasthenia gravis | Azathioprine | Health aspects | Analysis | Studies | Immunoglobulins | Autoimmune diseases | Rodents | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2570 - 2581
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myasthenia Gravis - classification | Thymectomy | Immunoglobulins, Intravenous - therapeutic use | Myasthenia Gravis - physiopathology | Comorbidity | Humans | Myasthenia Gravis - therapy | Plasma Exchange | Cholinesterase Inhibitors - therapeutic use | Care and treatment | Receptors | Acetylcholine | Myasthenia gravis | Diagnosis | Research | Immunoglobulins | Neuromuscular diseases | Autoantibodies | Thymoma | Neuromuscular junctions | Myasthenia | Autoimmune diseases | Immunosuppressive agents | Index Medicus | Abridged Index Medicus
Journal Article
Muscle & nerve, ISSN 0148-639X, 02/2008, Volume 37, Issue 2, pp. 141 - 149
myasthenia gravis, ocular myasthenia gravis | muscle fatigue | excitation‐contraction coupling | generalized myasthenia gravis | muscle weakness | acetylcholine receptor antibodies | Acetylcholine receptor antibodies | Muscle weakness | Myasthenia gravis, ocular myasthenia gravis | Excitation-contraction coupling | Generalized myasthenia gravis | Muscle fatigue | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Muscle | Medical sciences | Diseases of striated muscles. Neuromuscular diseases | Pharmacology. Drug treatments | Myasthenia Gravis - epidemiology | Myasthenia Gravis - mortality | Humans | Middle Aged | Myasthenia Gravis - therapy | Male | Disease Progression | Myasthenia Gravis - physiopathology | Thymectomy - methods | Age of Onset | Sex Factors | Aged, 80 and over | Adult | Female | Receptors, Cholinergic - immunology | Aged | Retrospective Studies | Index Medicus
Journal Article
Clinical and experimental immunology, ISSN 0009-9104, 03/2014, Volume 175, Issue 3, pp. 408 - 418
myasthenia gravis | diagnostics | neuroimmunology | therapy/immunotherapy | Myasthenia gravis | Therapy/immunotherapy | Diagnostics | Neuroimmunology | Life Sciences & Biomedicine | Immunology | Science & Technology | Myasthenia Gravis - epidemiology | Myasthenia Gravis - diagnosis | Myasthenia Gravis - drug therapy | Myasthenia Gravis - etiology | Humans | Autoimmune diseases | Medical prognosis | Immune system | Index Medicus | Review | therapy | immunotherapy
Journal Article
Nature reviews. Neurology, ISSN 1759-4758, 05/2016, Volume 12, Issue 5, pp. 259 - 268
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Myasthenia Gravis - classification | Myasthenia Gravis - blood | Myasthenia Gravis - physiopathology | Autoantibodies - blood | Humans | Myasthenia Gravis - therapy | Biomarkers - blood | Neuromuscular Junction - immunology | Index Medicus
Journal Article